Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMA - Spinal Muscular Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01754441
What this trial is testing

Mechanisms of Cell Death in Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Nemours Children's Clinic 25
Testing effectiveness (Phase 2)Looking for participantsNCT06421831
What this trial is testing

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Who this might be right for
Spinal Muscular Atrophy Type 3
GeneCradle Inc 21
Not applicableStudy completedNCT04813601
What this trial is testing

Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral Palsy

Who this might be right for
Neuromuscular DiseasesCerebral PalsySMA II
MarsiBionics 10
Testing effectiveness (Phase 2)Ended earlyNCT03196375
What this trial is testing

Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Who this might be right for
Motor Neuron Disease
Flex Pharma, Inc. 54
Testing effectiveness (Phase 2)Study completedNCT01703988
What this trial is testing

An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Biogen 34
Not applicableLooking for participantsNCT05663008
What this trial is testing

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)Postpoliomyelitis SyndromeSpinal Muscular Atrophy
University of Dublin, Trinity College 400
Not applicableLooking for participantsNCT07223489
What this trial is testing

Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System

Who this might be right for
Spinal Muscular Atrophy (SMA)
Medstar Health Research Institute 200
Not applicableWithdrawnNCT01663584
What this trial is testing

Multi-disease Carrier Screening Test Validation

Who this might be right for
Spinal Muscular Atrophy (SMA)Carrier ScreeningGenetic Testing
Natera, Inc.
Not applicableLooking for participantsNCT03217578
What this trial is testing

Neonatal Spinal Muscular Atrophy (SMA) Screening

Who this might be right for
Spinal Muscular Atrophy
Kaohsiung Medical University Chung-Ho Memorial Hospital 250,000
Not applicableStudy completedNCT07378943
What this trial is testing

Dosing Patterns and Costs in Patients With Spinal Muscular Atrophy Receiving Disease Modifying Therapies

Who this might be right for
Muscular Atrophy, Spinal
Novartis Pharmaceuticals 4,114
Not applicableStudy completedNCT02574390
What this trial is testing

Answer ALS: Individualized Initiative for ALS Discovery

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more
Johns Hopkins University 1,049
Testing effectiveness (Phase 2)Looking for participantsNCT07287982
What this trial is testing

Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy (SMA)
argenx 60
Early research (Phase 1)Study completedNCT02633709
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) Given by Mouth in Healthy Volunteers

Who this might be right for
Spinal Muscular Atrophy
Hoffmann-La Roche 33
Testing effectiveness (Phase 2)Ended earlyNCT03819660
What this trial is testing

Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3

Who this might be right for
Spinal Muscular Atrophy Type 3
Catalyst Pharmaceuticals, Inc. 13
Large-scale testing (Phase 3)Study completedNCT05156320
What this trial is testing

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+7 more
Scholar Rock, Inc. 188
Not applicableUnknownNCT03520179
What this trial is testing

Improving Standards of Care and Translational Research in Spinal Muscular Atrophy (SMA)

Who this might be right for
Spinal Muscular Atrophy
Great Ormond Street Hospital for Children NHS Foundation Trust 600
Post-approval studies (Phase 4)Study completedNCT04488133
What this trial is testing

Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)

Who this might be right for
Muscular Atrophy, Spinal
Biogen 46
Not applicableLooking for participantsNCT06756633
What this trial is testing

Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases

Who this might be right for
Neuromuscular Diseases in ChildrenRespiratory Function ImpairedRespiratory Insufficiency+3 more
Lokman Hekim University 42
Not applicableStudy completedNCT02156141
What this trial is testing

High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy

Who this might be right for
Spinal and Bulbar Muscular AtrophyHealthy Subjects
Karen Brorup Heje Pedersen 10
Not applicableStudy completedNCT03560661
What this trial is testing

Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisKennedy's Disease
Assistance Publique - Hôpitaux de Paris 71
Next Page